The dosing frequency of liraglutide was correctly noted in Table 1 of the article but incorrectly noted in Table 4. In both tables, the frequency should be once daily. The online version of this article was updated to reflect this change.
. 2024 Aug 13;42(4):583. doi: 10.2337/cd24-er04
Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467–473
Heather P Whitley
, Jennifer M Trujillo
, Joshua J Neumiller
Heather P Whitley
Find articles by Heather P Whitley
Jennifer M Trujillo
Find articles by Jennifer M Trujillo
Joshua J Neumiller
Find articles by Joshua J Neumiller
Collection date 2024 Fall.
© 2024 by the American Diabetes Association
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
PMCID: PMC11486853 PMID: 39429459
This corrects the article "Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages" in volume 41 on page 467.